What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Disease
His primary areas of investigation include Internal medicine, Cardiology, Heart failure, Coronary artery disease and Blood pressure.
His research on Internal medicine frequently links to adjacent areas such as Diabetes mellitus.
His studies in Cardiology integrate themes in fields like Surgery, Vascular disease and Incidence.
His Heart failure research includes themes of Proportional hazards model, Cohort and Hazard ratio.
His Coronary artery disease research is multidisciplinary, relying on both Intermittent claudication, Dyslipidemia and Epidemiology.
As part of the same scientific family, Wilbert S. Aronow usually focuses on Blood pressure, concentrating on Guideline and intersecting with Treatment outcome and Treatment adherence.
His most cited work include:
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (2418 citations)
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (1880 citations)
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (574 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Cardiology, Heart failure, Myocardial infarction and Coronary artery disease.
His Internal medicine study frequently links to related topics such as Diabetes mellitus.
His research integrates issues of Prospective cohort study, Surgery, Incidence and Risk factor in his study of Cardiology.
The Heart failure study which covers Intensive care medicine that intersects with Disease.
His study in Percutaneous coronary intervention and Revascularization is carried out as part of his studies in Myocardial infarction.
His Coronary artery disease study frequently draws connections between adjacent fields such as Aspirin.
He most often published in these fields:
- Internal medicine (75.85%)
- Cardiology (60.99%)
- Heart failure (23.80%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (75.85%)
- Cardiology (60.99%)
- Heart failure (23.80%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, In patient and Myocardial infarction.
His studies in Randomized controlled trial, Meta-analysis, Ejection fraction, Blood pressure and Confidence interval are all subfields of Internal medicine research.
Wilbert S. Aronow has included themes like Stroke and Disease in his Cardiology study.
The Heart failure study combines topics in areas such as Propensity score matching and Intensive care medicine.
He connects In patient with Surgery in his study.
His Myocardial infarction study integrates concerns from other disciplines, such as Diabetes mellitus and Kidney disease.
Between 2017 and 2021, his most popular works were:
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (2418 citations)
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (1880 citations)
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (574 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Myocardial infarction
The scientist’s investigation covers issues in Internal medicine, Cardiology, Heart failure, Randomized controlled trial and Blood pressure.
Wilbert S. Aronow undertakes multidisciplinary investigations into Internal medicine and In patient in his work.
He has researched Cardiology in several fields, including Valsartan and Propensity score matching.
Wilbert S. Aronow works mostly in the field of Heart failure, limiting it down to topics relating to Intensive care medicine and, in certain cases, Risk factor, as a part of the same area of interest.
His Randomized controlled trial research incorporates themes from Stroke, Odds ratio and Acute coronary syndrome.
His work on Antihypertensive drug as part of his general Blood pressure study is frequently connected to Clinical Practice and Task force, thereby bridging the divide between different branches of science.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
